News

AI might already be hiding its real capabilities. That’s what Dr. Roman Yampolskiy told Rogan in a podcast episode that will ...
Today, these microbial partners work in the soil across millions of acres of farmland worldwide, helping farmers grow more ...
Synthetic biology holds much promise for the life sciences sector as it continues to look for new ways of treating disease and accelerating drug development, says Debiopharm's Tanja Dowe ...
The partners will use UNP's AI-based macrocycle discovery platform to develop synthetic peptide therapeutics for multiple disease targets.
A startup called Gigablue claims to have reached a milestone by selling 200,000 carbon credits for its ocean-based carbon ...
The Korvaa Consortium tapped Modern Synthesis, Ecovative and Ourobio to develop the debut shoe made with mycelium, bacterial ...
Karandikar emphasised that the operational framework for the R&D Innovation Scheme fund is being finalised and will roll out ...
When it comes to cutting-edge health technology, Jecizer Biosciences is quickly becoming the name you’ve probably haven’t ...